476 related articles for article (PubMed ID: 36315056)
21. Biodegradable Silica-Based Nanotheranostics for Precise MRI/NIR-II Fluorescence Imaging and Self-Reinforcing Antitumor Therapy.
Zheng Z; Jia Z; Qu C; Dai R; Qin Y; Rong S; Liu Y; Cheng Z; Zhang R
Small; 2021 Mar; 17(10):e2006508. PubMed ID: 33569918
[TBL] [Abstract][Full Text] [Related]
22. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
23. Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy.
Wang J; Kong W; Jin H; Li C; Luo Q; Luo Y; Yuan C; Lu J; Zhang L; Liu X
Colloids Surf B Biointerfaces; 2022 Oct; 218():112750. PubMed ID: 35961116
[TBL] [Abstract][Full Text] [Related]
24. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
[TBL] [Abstract][Full Text] [Related]
25. H
Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
[TBL] [Abstract][Full Text] [Related]
26. A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H
Liu M; Xu H; Zhou F; Gong X; Tan S; He Y
J Mater Chem B; 2023 Nov; 11(45):10822-10835. PubMed ID: 37920970
[TBL] [Abstract][Full Text] [Related]
27. Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy.
Liang J; Sun Y; Wang K; Zhang Y; Guo L; Bao Z; Wang D; Xu H; Zheng J; Yuan Y
ACS Appl Mater Interfaces; 2023 Apr; 15(14):18191-18204. PubMed ID: 36975190
[TBL] [Abstract][Full Text] [Related]
28. Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors.
Zhao DH; Li CQ; Hou XL; Xie XT; Zhang B; Wu GY; Jin F; Zhao YD; Liu B
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55780-55789. PubMed ID: 34787410
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
30. Copper peroxide coated upconversion nanoparticle modified with glucose oxidase for H
Hong Y; Tao Q; Liu YY; Wang Z; Wang H; Sun L
Dalton Trans; 2022 Aug; 51(30):11325-11334. PubMed ID: 35838196
[TBL] [Abstract][Full Text] [Related]
31. Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC.
Chen W; Hu F; Gao Q; Zheng C; Bai Q; Liu J; Sun N; Zhang W; Zhang Y; Dong K; Lu T
J Nanobiotechnology; 2024 Mar; 22(1):98. PubMed ID: 38461231
[TBL] [Abstract][Full Text] [Related]
32. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
[TBL] [Abstract][Full Text] [Related]
33. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
34. One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy.
Zhang L; Yang Z; He W; Ren J; Wong CY
J Colloid Interface Sci; 2021 Oct; 599():543-555. PubMed ID: 33964699
[TBL] [Abstract][Full Text] [Related]
35. Dual catalytic cascaded nanoplatform for photo/chemodynamic/starvation synergistic therapy.
Gu D; Liu Z; Wu H; An P; Zhi X; Yin Y; Liu W; Sun B
Colloids Surf B Biointerfaces; 2021 Mar; 199():111538. PubMed ID: 33383548
[TBL] [Abstract][Full Text] [Related]
36. Ultrasmall gold decorated bimetallic metal-organic framework based nanoprobes for enhanced chemodynamic therapy with triple amplification.
Geng T; Zhang J; Wang Z; Shi Y; Shi Y; Zeng L
J Mater Chem B; 2023 Mar; 11(10):2249-2257. PubMed ID: 36794807
[TBL] [Abstract][Full Text] [Related]
37. One-Pot Rapid Synthesis of Cu
Li Q; Yu J; Lin L; Zhu Y; Wei Z; Wan F; Zhang X; He F; Tian L
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16482-16491. PubMed ID: 36972557
[TBL] [Abstract][Full Text] [Related]
38. Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy.
Zhou S; Xu J; Dai Y; Wei Y; Chen L; Feng W; Chen Y; Ni X
Biomater Res; 2022 Nov; 26(1):66. PubMed ID: 36435848
[TBL] [Abstract][Full Text] [Related]
39. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
[TBL] [Abstract][Full Text] [Related]
40. NIR-II-responsive AuNRs@SiO
Wen C; Guo X; Gao C; Zhu Z; Meng N; Shen XC; Liang H
J Mater Chem B; 2022 Jun; 10(22):4274-4284. PubMed ID: 35583909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
